![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, May 21, 2019 5:41:39 PM
I wonder who convinced John Springs Stafford to step into this mess, though the fines paid out by hedge funds for collusion will certainly be a risk they had to take it seems
TIM recognition of phosphatidylserine regulates innate and adaptive immunity
Freeman, Gordon James
Dana-Farber Cancer Institute, Boston, MA, United States
The goal of Project 2 is to understand how TIM proteins regulate immune responses and autoimmunity via their recognition of phosphatidylserine on apoptotic cells. We discovered the Tim (T cell- Imunoglobulin-Mucin) genes, which we showed regulate tolerance, Th2 cytokine production, and asthma. We propose to:
Specific Aim 1.
Determine the functional consequences of TIM-4 and TIM-3 on APC binding to phosphatidylserine on apoptotic cells. We will examine effects on (a) anti-inflammatory cytokine production: IL-10, TGF-|3;(b) expression of coinhibitory molecules: PD-L1, PD-L2, B7-H3, B7-H4;(c) expression of co-stimulatory molecules: B7-1, B7-2, ICOS-L, CD40;(d) PGE2 and IDO production.
Specific Aim 2.
Determine the functional consequences of TIM-4 and TIM-3 on APC binding to phosphatidylserine in a pro-inflammatory context and determine the effects of TIM-1 and TIM-3 on T cells binding to PtdSer on an apoptotic APC. We will examine the (a) effects of TIM-4 or TIM-3 mediated phagocytosis of apoptotic versus necrotic cells on APC function in pro-inflammatory conditions;(b) determine the effects on T cell activation and TReg development of TIM-1 and TIM-3 on T cells binding to PtdSer on an apoptotic APC;and (c) determine how the health of the APC regulates T cell responses through TIM-1 and TIM-3.
Specific Aim 3.
Determine the structure/function relationship of TIM alleles on recognition of phosphatidylserine, phagocytosis, and T cell activation. We will perform a mutational analysis of the TIM-4 phosphatidylserine binding site and functional consequences of these mutations on phagocytosis;determine if HBA and BALB/c alleles of TIM-1 and TIM-3 have different capacities to recognize PtdSer and phagocytose apoptotic cells;and (c) determine how TIM-1 costimulation affects T cell activation in vitro and compare responses of TIM-1-expressing T cells from HBA and BALB/c mice. These studies together will greatly increase our understanding of the function of TIMs in the regulation of tolerance and Th2 responses, and will characterize a crucial regulator of CD4 T cell differentiation and a novel and extremely important asthma susceptibility gene family.
Public Health Relevance
TIM proteins recognize dead cells and help remove them from the body. We will find out how the TIMs remove dead cells and how this regulates the immune response. This will allow us to understand the development of and design therapies for asthma, allergies, and autoimmune disease.
http://grantome.com/grant/NIH/P01-AI054456-11-7255
_________
http://www.dfhcc.harvard.edu/insider/member-detail/member/gordon-j-freeman-phd/
Recent CDMO News
- Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance • GlobeNewswire Inc. • 05/23/2024 12:05:46 PM
- Avid Bioservices to Participate at Upcoming Investor Conferences • GlobeNewswire Inc. • 05/07/2024 08:05:11 PM
- Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 04/24/2024 09:25:33 PM
- Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q • GlobeNewswire Inc. • 03/20/2024 11:00:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 11:30:11 AM
- Avid Bioservices Announces Pricing of Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/07/2024 04:58:48 AM
- Avid Bioservices Announces Proposed Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/06/2024 09:32:07 PM
- Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 03/06/2024 09:31:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:30:18 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:57:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 12:34:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:39:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:38:30 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:37:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:36:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:35:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/11/2024 12:56:02 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/08/2024 09:32:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:56:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:55:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:53:58 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:51:57 AM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 12/19/2023 09:05:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 12:34:08 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM